Home
Scholarly Works
Development of OAT-1746, a novel arginase 1 and 2...
Conference

Development of OAT-1746, a novel arginase 1 and 2 inhibitor for cancer immunotherapy

Authors

Stanczak PS; Grzybowski MM; Wolska P; Zdziarska AM; Mazurkiewicz M; Blaszczyk R; Nowicka J; Sosnowska A; Ramji K; Nowis D

Volume

28

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2017

Name of conference

42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference place

SPAIN, Madrid

Conference start date

September 8, 2017

Conference end date

September 12, 2017

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team